Recent Advances in Cancer Drug Development and Pharmaceutical Analysis: An In-Depth Review

Abstract

Author(s): Sai Lekhya Kothapalli* and Jeya Prakash M.R.

Cancer continues to be a leading cause of death globally, necessitating the continuous development of effective therapeutic strategies. This review provides an in-depth exploration of the current landscape of cancer drug development, with a particular focus on pharmaceutical analysis techniques used to optimize the efficacy, safety, and accessibility of these therapies. It covers various classes of cancer drugs, including chemotherapy, targeted therapies, immunotherapies, and hormonal treatments, examining their mechanisms of action and clinical application. The role of pharmaceutical analysis, such as pharmacokinetics (PK), pharmacodynamics (PD), and bioavailability testing, is discussed, with insights into analytical techniques like HPLC, mass spectrometry, and spectroscopy. Additionally, advances in drug delivery systems, such as nanoparticle-based and targeted delivery methods, are explored in the context of improving therapeutic outcomes and minimizing side effects. Challenges in cancer drug development, such as drug resistance, toxicity, and high costs, are addressed, alongside strategies for overcoming these hurdles. Finally, the review highlights emerging trends in cancer therapy, including the potential of personalized medicine, artificial intelligence in drug discovery, and gene therapies, pointing to the future of cancer treatment.

Share this article